Apoptosis is induced by the transcriptional inhibitor actinomycin D (Act D) in various cell types, particularly many leukemic cell lines such as HL-60. A common feature of these cell lines is their high constitutive expression level of the nbl gene, which was originally isolated by virtue of its abundance in a Namalwa Burkitt lymphoma cDNA library. In contrast, cell lines which constitutively express nbl at low levels appear not to undergo typical apoptotic death in response to Act D. Apoptotic induction by Act D in cells which normally express nbl at high levels was found in this study to be closely associated with a decline in nbl mRNA levels, raising the possibility that apoptosis could be induced by lowering nbl expression levels in such cells. Transient expression of nbl antisense sequences in HL-60 cells decreased cell viability, and induced typical apoptotic morphology such as cell shrinkage, chromatin condensation and nuclear fragmentation. Incubation with nbl antisense oligomers also induced similar features in HL-60 cells and in another high nbl-expressing cell line, Jurkat, but had little effect in HepG2 cells which constitutively express nbl at low levels. These findings suggest that lowering constitutively high levels of nbl expression can induce apoptosis.
Introduction
Cell death via apoptosis, like the opposing process of cell proliferation, is a dynamic phenomenon involving changes in expression of specific genes and in activity of specific gene products. The possibility that apoptosis could be triggered, at least in some cases, by suppressing a constitutively expressed factor(s) was initially raised by observations that various cell types, in particular many leukemia and lymphoma cell lines, undergo apoptosis in response to transcriptional and translational inhibitors. 1 Although disintegration of the gene expression machinery and of genetic material is an eventuality of cell death, several studies have demonstrated, primarily using antisense strategies, that suppressing specific genes can trigger apoptosis in certain cell types. Many such genes appear to be oncogenes. For example, antisense oligomers targeting c-fes mRNA can induce apoptosis in promyelocytic leukemia cells, 2 while antisense oligomers targeting the mRNAs of bcrabl and bcl-2 can induce apoptosis in chronic and in acute myelogenous leukemia cells, respectively. 3, 4 The nbl gene was originally isolated by virtue of its abundance in a Namalwa Burkitt lymphoma cDNA library. 5 In earlier work, we observed a marked enhancement and a subsequent abrupt halt in nbl expression during glucocorticoidinduced thymic apoptosis in vivo. 5 More recently, we have found that apoptosis can be induced by the transcriptional inhibitor actinomycin D (Act D) in a variety of human cell
Correspondence: H Naora, Research School of Biological Sciences, The Australian National University, GPO Box 475, Canberra, A.C.T. 2601, Australia; Fax: 612 62 47 36 43 Received 7 May 1997; accepted 18 November 1997 lines which constitutively express the nbl gene at high levels. 6 The promyelocytic leukemia cell line HL-60 shows a particularly strong susceptibility to apoptotic induction by Act D and constitutively expresses nbl at very high levels. 6 In contrast, cell lines with low constitutive levels of nbl expression show no typical apoptotic features when treated with Act D. 6 It was therefore of interest to investigate whether apoptosis could be induced by lowering the levels of nbl expression in cells which normally express this gene at high levels. In this study, we examined in HL-60 cells the effects of transient expression of nbl antisense sequences and of incubation with nbl antisense phosphorothioate oligomers. The effects of nbl antisense oligomers were also compared in other cell lines which constitutively express nbl at high and at low levels. The findings suggest that lowering constitutively high levels of nbl expression can trigger cell death.
Materials and methods

Culture and microscopic examination of human cells
Culture of HL-60 cells, histiocytic lymphoma U937, T cell leukemia Jurkat, bladder carcinoma 5637, Chang liver cells and hepatoma HepG2, and the treatment of cells with Act D (Sigma, St Louis, MO, USA) is described elsewhere. 6, 7 The plasmacytoma HS-Sultan was cultured as described for HL-60 cells. Assessment of cell viability by trypan blue dye exclusion, and of cell morphology is described elsewhere. 6, 8 Free cells, gently trypsinized cells or cell aggregates were prepared for Giemsa-staining by cytocentrifugation to allow detailed examination of chromatin distribution, as a result of which some cytoplasmic integrity was sacrificed. Ninety-sixwell plates were coated with poly 2-hydroxyethylmethacrylate (poly(HEMA)) (Sigma) as described. 9 Transient expression of nbl antisense sequences
The pMSG vector (Pharmacia, Uppsala, Sweden) contains the murine mammary tumour virus long terminal repeat (MMTV LTR) upstream of a polylinker. The 0.9 kb nbl cDNA clone 5 was cloned in antisense orientation into SmaI/XhoI polylinker sites to produce plasmid pMSG-anti-nbl. The cationic, lipophilic reagent Tfx-50 (Promega, Madison, WI, USA) was used to improve transfection efficiency of HL-60 cells. HL-60 cells (4 × 10 4 ), suspended in serum-free medium, were transfected with 0.16 g or 0.24 g of pMSG-anti-nbl DNA at a Tfx-50:DNA charge ratio of 3:1 in a total volume of 40 l. The same procedure was used to transfect HL-60 cells with pMSG vector DNA. Two hours after transfection at 37°C, 200 l of medium containing 10% serum and 1 M dexamethasone (DEX) (Sigma) was added to the cells. Cell morphology and viability were assessed after incubation with DEX for 2 days.
For isolation of RNA and protein, transfection was carried out using 1 × 10 6 and 2 × 10 6 cells, respectively, at the same DNA concentrations and Tfx-50:DNA ratio as in the small-scale experiments. Volumes for transfection and incubation with DEX were scaled up accordingly.
cDNA probes, isolation and analysis of RNA and DNA The nbl cDNA probe, RNA isolation and Northern blot analysis, and the quantitation of hybridization signals by PhosphorImager analysis (Molecular Dynamics, Sunnyvale, CA, USA) has been described elsewhere. 5 The 1.0 kb human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA was obtained from Clontech (Palo Alto, CA, USA). RNA filters were stripped of hybridizing material by washing at 70°C in 0.1% SDS prior to rehybridizing with a different DNA probe. Correction for RNA content, by hybridization with the 0.97 kb 18S ribosomal DNA fragment derived from plasmid pX1r14F, 10 is described elsewhere. 6 Isolation and agarose gel electrophoresis of genomic DNA is described elsewhere. 5 The extent of DNA fragmentation (Ͻ50 kb) was quantified by laser densitometric analysis of negatives of gel photographs. 5 Isolation and analysis of protein Approximately 2 × 10 6 cells were resuspended in RIPA buffer (20 mM Tris-Cl (pH 7.4), 100 mM NaCl, 0.1% Tween-20, 5 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM sodium fluoride, 1 mM sodium pyrophosphate, 12 M ␤-glycerophosphate, 10 M pepstatin A, 10 M leupeptin, 200 M phenylmethyl-sulfonyl fluoride). After incubation on ice for 15 min, the lysate was centrifuged at 12 000 g for 5 min at 4°C. Protein content of the supernatant was determined using a BioRad kit (Hercules, CA, USA). Equal amounts of protein per lane (12 g) were electrophoresed on a 10% SDS-polyacrylamide mini-gel (Bio-Rad), and electro-transferred to Hybond-C membrane (Amersham, Bucks, UK). The membrane was stained with Ponceau S (Sigma) to verify equal protein content in lanes, and blocked overnight in TBS (10 mM Tris-Cl (pH 7.3), 150 mM NaCl) containing 0.05% Tween-20 and 5% nonfat milk powder. The membrane was incubated sequentially with: (1) polyclonal antiserum raised in rabbits against a synthetic peptide comprising amino acid residues 241 to 264 of the nbl protein, as predicted from the nbl cDNA sequence (1:2000); (2) anti-rabbit Ig biotinylated F(abЈ) 2 fragment (Amersham) (1:300); and (3) streptavidin-biotinylated horseradish peroxidase complex (Amersham) (1:500). Each incubation was carried out for 1 h, followed by three 5-min washes in TBS containing Tween-20. nbl protein was visualised by treatment with 4-chloro-1-naphthol (0.5 mg/ml) (Amersham) in TBS containing H 2 O 2 (0.1% (v/v)).
Phosphorothioate oligomers
Phosphorothioate oligomers were synthesized and HPLCpurified by the Biomolecular Research Facility (Australian National University, Canberra, Australia). The sequence of the nbl antisense oligomer was complementary to the ATG initiation codon and the next four codons and was as follows: 5Ј-CTTGCCAACCGCCAT-3Ј. A control oligomer contained random sequences of the same base composition as the nbl antisense oligomer as follows: 5Ј-TCCAAGCCTTACGCC-3Ј. A nbl sense oligomer contained sequences of the initiation codon and the next four codons. Oligomers were dissolved in H 2 O and added at concentrations described below to 1 × 10 4 cells resuspended in 100 l fresh medium in 96-well plates. At least two different batches of each oligomer were tested.
Labeling of free 3Ј-OH ends on DNA Cells were fixed in formaldehyde as described elsewhere. 11 In situ labeling was carried out using a DNA 3Ј-end labeling kit (Boehringer Mannheim, Mannheim, Germany). Cells possessing labeled DNA were precipitated and collected on to nitrocellulose filters (Type HA; Millipore Corporation, Bedford, MA, USA) using cold 10% trichloroacetic acid, and extent of fragmentation assessed by scintillation counting. The DNA 3Ј-end labeling kit was also used to label free 3Ј-OH ends on isolated genomic DNA. Labeled DNA was electrophoresed on 6% polyacrylamide/8 M urea gels and extent of DNA fragmentation assessed by quantifying radioactivity incorporated in DNA of Ͻ50 kb in length using PhosphorImager analysis.
Results
Suppression of nbl expression and apoptotic induction by Act D
Act D has been observed to induce morphological changes and internucleosomal DNA cleavage typical of apoptosis in a variety of human cell lines which constitutively express nbl at high levels above a certain 'threshold', defined as approximately 5-to 6-fold the low constitutive nbl mRNA level in normal human placenta. 6 Residual nbl mRNA levels detected in these cells after Act D addition showed a strong inverse correlation to the degree of DNA fragmentation induced ( Figure 1 ). This relationship did not appear due to possible variation in ability of Act D to effectively penetrate different cell types, as changes in myc and ubiquitin transcript levels, following Act D addition, do not significantly vary among a range of cells which markedly differ in the degree of DNA fragmentation induced. 6 While the level to which high constitutive nbl expression falls to, following Act D addition, appears closely associated with the degree of apoptosis induced, changes in ␤-actin mRNA levels among several of these cell lines in response to Act D show no such correlation with apoptosis. 7 
Transient expression of nbl antisense sequences
To establish whether the nature of the relationship between a fall from high constitutive nbl levels and apoptotic induction was causal, coincidental or consequential, we investigated the effect of transiently expressing nbl antisense sequences in HL-60 cells. This cell line was used as a model system in view of its high constitutive nbl expression 6 and because its morphological changes under various apoptosis-inducing conditions have been well-studied. 1, 6, 11, 12 HL-60 cells were transfected with a plasmid comprising of nbl cDNA sequences cloned in antisense orientation into the pMSG vector (pMSGanti-nbl). This vector allows DEX-inducible, MMTV LTRdriven expression of cloned sequences and has been used for Relationship between levels of residual nbl mRNA and DNA fragmentation. nbl mRNA levels detected in cells at 6 h after Act D addition (1 g/ml) were quantified by PhosphorImager analysis and expressed relative to the constitutive nbl mRNA level in placenta. Residual nbl mRNA levels were corrected for RNA content using 18S hybridization signals, and plotted against the degree of DNA fragmentation induced by Act D, as quantified by laser densitometry and expressed as an increment above the low basal level of DNA fragmentation in untreated cells. Results represent mean ± s.d. of three or four experiments. (⌬), indicates the level to which nbl mRNAs decline when all the genomic DNA is fragmented in the apoptotic cell, as obtained by extrapolation from the statistically calculated regression curve (dotted line). efficient antisense-mediated inhibition of other genes. 13 Following transfection, cells were stimulated with DEX for 2 days. Significant induction of nbl antisense transcripts occurred when pMSG-anti-nbl-transfected cells were stimulated with DEX ( Figure 2 ). This induction of nbl antisense transcripts led to a marked reduction in the level of nbl protein ( Figure 3 ). When compared with cultures of untransfected cells or of cells transfected with pMSG vector, a significant increase in numbers of cells which exhibited shrinkage and membrane blebbing characteristic of apoptosis 8 was observed in cultures of pMSG-anti-nbl-transfected cells. A similar increase in numbers of cells taking up trypan blue dye was also induced. The total number of dead cells and cells exhibiting typical apoptotic morphology shown in Figure 4 comprised almost half of the total cell population. In addition, DEX-stimulated MMTV LTR-driven nbl antisense transcription induced marked chromatin condensation, and nuclear and cell fragmentation (Figure 5b and c). Such features were very similar to those observed in HL-60 cells treated with Act D and other apoptosis-inducing agents. 1, 6, 11 Increases in numbers of both apoptotic and non-viable cells were dependent on the dose of transfected nbl antisense DNA sequences. In contrast, such induction of apoptotic morphology and loss of viability were not observed when HL-60 cells were transfected with varying amounts of pMSG vector DNA (Figures 4 and 5a) .
Various observations indicate that apoptotic cell death . Northern blot analysis was performed using the nbl cDNA to probe 8 g RNA isolated from these cells. Endogenous nbl mRNAs were detected in all samples. A high level of a longer transcript containing nbl antisense sequences, and a small amount of its partially spliced species were only detected in pMSG-anti-nbl-transfected cells. Equal RNA content in lanes was confirmed by re-probing with the 18S probe.
induced in HL-60 cells by nbl antisense transcripts is not due to possible non-specific effects associated with transfection. Although proliferation was suppressed following transfection, little difference in numbers of apoptotic and dead cells was observed between cultures of untransfected and pMSG vectortransfected cells (Figure 4 ). This indicates that the significant increase in numbers of apoptotic and dead cells in pMSGanti-nbl-transfected cultures is not attributable to possible inhibitory side-effects of the transfection reagent or of vector sequences present in plasmid pMSG-anti-nbl. Induction of apoptotic cell death was reproducible using different batches of pMSG-anti-nbl plasmid DNA prepared using the same method as for pMSG vector DNA. Although DEX itself is known to induce apoptosis in some cell types such as thymocytes, 5 growth curve analysis of untransfected HL-60 cells indicated that cell proliferation and the numbers of apoptotic and dead cells were unaffected by DEX. Furthermore, endogenous nbl expression in HL-60 cells was unaffected by DEX ( Figure 2 ). pMSG-anti-nbl-transfected cells incubated without DEX did not represent a suitable control in view of the presence (albeit small) of various MMTV LTR-stimulatory hormones in the culture medium. Extending the DEX incubation time from 2 to 3 days did not lead to further increase Decrease in nbl protein levels by nbl antisense transcription. HL-60 cells were transfected with pMSG vector (lane 2) or pMSG-anti-nbl (lane 3) using DNA and Tfx-50 concentrations described in Figure 2 , and then stimulated with DEX for 2 days. Untransfected cells were also stimulated with DEX for 2 days (lane 1). nbl protein in these cells was detected by Western blot analysis using polyclonal nbl antiserum. Positions of prestained molecular weight standards are indicated (in kDa).
in cell death in pMSG-anti-nbl-transfected cultures. This observation concurs with the fact that maximum transient transcription in the present system occurs at 2 days after transfection, followed by rapid cessation.
Specific effect of nbl antisense oligomers on nbl mRNA levels To confirm our observations of the apoptosis-inducing ability of transient nbl antisense transcription, we investigated the effect of incubating HL-60 cells with nbl antisense phosphorothioate oligomers targeting the initiation codon region. These oligomers were used at a range of concentrations and for periods of time commonly used in other studies. 2, 3, 14, 15 Their effectiveness and specificity in inhibiting nbl expression were examined in preliminary experiments. The nbl mRNA level was reduced in HL-60 cells incubated with nbl antisense oligomers, as compared with the level in untreated cells (Figure 6a ). It is generally believed that the inhibitory effect of antisense phosphorothioate oligomers involves degradation of the targeted mRNA by RNase H. 16 Although some antisense oligomers can inhibit protein synthesis without altering targeted mRNA levels, 17 the result in the present model suggests that nbl antisense oligomers inhibit nbl expression, at least in part, by an RNase H-dependent mechanism. The reduction in the nbl mRNA level is of an order similar to those found in antisense studies targeting other mRNA species under similar incubation conditions. 3,14 nbl antisense oligomers appeared to be specific for the targeted mRNA. Incubation of HL-60 cells with phosphorothioate oligomers composed of random nbl antisense oligomers showed a marked increase in numbers of non-viable cells and of cells exhibiting marked shrinkage and blebbing, as was seen in HL-60 cultures treated with Act D 6 or transiently expressing nbl antisense sequences (Figures 4 and 7a) . Likewise, HL-60 cells incubated with nbl antisense oligomers exhibited typical chromatin condensation, and nuclear and cell fragmentation (Figure 8c and d) . Increases in numbers of apoptotic and non-viable cells were observed to be time-dependent in cultures treated with nbl antisense oligomers over a 3-day time course, and strictly correlated with increases in oligomer concentrations from 0 to 40 M. In contrast, no such concentration-dependent effect was observed with random oligomers. In fact, HL-60 cells incubated with random oligomers exhibited no significant difference in viability or morphology from untreated cells (Figures 7a and 8a and b) . Incubation with nbl sense oligomers, containing sequences of the initiation codon and the next four codons, produced results in general similar to those observed with random oligomers. These findings indicate that the cell death induced by nbl antisense oligomers is not due to possible nonsequence-specific effects of phosphorothioate oligomers.
It is possible that nbl antisense oligomers could induce apoptosis and loss of viability by a sequence-specific, nonantisense mechanism. To our knowledge, nbl antisense oligomers did not contain sequences which have been reported to be growth-inhibitory such as GGC or 3Ј terminal TAT consensus sequences.
15,18 nbl antisense oligomers also did not contain G-stretches or GC-rich sequences at the 5Ј-and 3Ј-ends which often give rise to non-specific effects. 16 Although possible unknown side-effects of oligomers cannot be totally discounted, the observed biological effects of nbl antisense oligomers are likely to be largely attributable to inhibition of nbl expression, since very similar changes in morphology and viability were observed when nbl expression was inhibited by transient nbl antisense transcription (compare Figures 5b, 8c  and 4, 7a) .
In cultures treated with nbl antisense oligomers, apoptotic and non-viable cells were observed together with cells which appeared very similar to untreated cells (Figure 8a and c) . In view that random oligomers (Figure 8b and e) or nbl sense oligomers (data not shown) had little effect when compared with untreated cells, it is likely that nbl antisense oligomers were efficiently taken up by, and effectively blocked nbl expression in, cells which showed distinct apoptotic morphology and eventually died, whereas uptake and blockage was poorer in those cells which appeared similar to untreated cells. It should be noted that the observed reduction in nbl mRNA levels induced by nbl antisense oligomers (ෂ50%) (Figure 6a ) represents an average for a heterogenous population of cells. This correlates strongly with the observation that apoptotic and dead cells comprised approximately half of the total cell population under the same incubation conditions.
One interesting observation was that HL-60 cells incubated without oligomers or with random oligomers tended to aggregate. Cells in these aggregates showed prominent nucleoli (Figure 8a and b) . In contrast, cells incubated with nbl antisense oligomers exhibited extensive disaggregation ( Figure  8c ). HL-60 cells induced to undergo apoptosis by adenosine or cytochalasin B also appear more dispersed than untreated cells. 12 HL-60 cells in cultures treated with nbl antisense oligomers appeared almost evenly dispersed like a monolayer on the bottom of the well. To investigate whether this apparent attachment to the matrix modulated cell death induced by nbl antisense oligomers, we examined the effect of incubating oli-
Figure 6
Inhibition of nbl mRNA levels by nbl antisense oligomers. Levels of (a) nbl mRNA and of (b) GAPDH mRNA were com- gomer-treated cells in wells coated with poly(HEMA), a nontoxic, anti-adhesive polymer. 9 No significant enhancement or suppression of the apoptosis-inducing ability of nbl antisense oligomers was observed in HL-60 cells cultured in poly(HEMA)-coated wells. Whether the observed disaggregation of HL-60 cells and their contact with the matrix are involved in the apoptotic process, or is a side-effect of nbl antisense oligomers, is at present unclear and requires further investigation.
Induction of DNA fragmentation by nbl antisense oligomers
We also examined whether incubating HL-60 cells with nbl antisense oligomers could induce DNA fragmentation. DNA breaks were detected by labeling free 3Ј-OH ends with terminal deoxynucleotidyl transferase. There was little difference in the amount of DNA breaks detected in untreated HL-60 cells and in cells incubated with random oligomers (Figure  7b ). In contrast, nbl antisense oligomers induced a significant increase in DNA fragmentation in HL-60 cells after 2 days incubation, which correlated with appearance of typical apoptotic morphology and loss of viability (Figure 7a and b) . Similar results were obtained when DNA fragmentation was assessed by labeling breaks in isolated genomic DNA and by in situ labeling in fixed cells. Differential effect of nbl antisense oligomers in cells expressing nbl at high and at low levels As described earlier, cell lines which are susceptible to apoptotic induction by Act D constitutively express nbl at levels above a 'threshold' defined as 5-to 6-fold the constitutive nbl mRNA level in placenta. 6 It was therefore of interest to compare the effect of nbl antisense oligomers in other cell lines which constitutively express nbl at levels above and also below this 'threshold'. The T cell leukemia, Jurkat, constitutively expresses nbl at a level ෂ14-fold higher than in placenta. 6 Although HL-60 cells incubated with nbl antisense oligomers exhibited extensive disaggregation (Figure 8c ), Jurkat cells tended to remain aggregated (Figure 9b) . However, many cells in such aggregates exhibited chromatin condensation and nuclear fragmentation (Figure 9b) , as was induced in HL-60 cells. Such marked nuclear changes were not apparent in Jurkat cells which were untreated or incubated with random oligomers (Figure 9a and c) .
HepG2 cells constitutively express nbl at a level below that in placenta, and are unresponsive to Act D under conditions which trigger considerable apoptosis in HL-60 and Jurkat cells. 6 HepG2 cells incubated with nbl antisense oligomers (Figure 9e) showed no difference in chromatin distribution from HepG2 cells which were untreated or incubated with random oligomers (Figure 9d and f) . Likewise, there was no significant difference in viability between HepG2 cultures incubated with nbl antisense oligomers, and either untreated or random oligomer-treated cultures. In contrast, numbers of non-viable cells and of trypan blue dye-excluded cells exhibiting marked shrinkage and blebbing in Jurkat cultures treated with nbl antisense oligomers was at least 4-fold greater than numbers of such cells in untreated or random oligomertreated cultures. These results suggest that cells which constitutively express nbl at high levels are susceptible to apoptotic induction by nbl antisense oligomers, whereas cells which constitutively express nbl at low levels are not.
Discussion
The ability of macromolecular synthesis inhibitors such as Act D to induce apoptosis in various cell types has been proposed to involve inactivation of a labile repressor(s), which in turn would derepress the core apoptotic machinery, or inhibition of a crucial survival factor(s). 1, 19 The observed abilities of Act D and of nbl antisense sequences to induce apoptosis in cells which constitutively express nbl at high levels, and the associated fall in nbl levels, raises the possibility that nbl could be involved in a repressor or survival factor mechanism. However, we have observed that the normally low constitutive nbl level in mouse thymus is markedly enhanced following in vivo administration of the apoptosis-inducing agent DEX, and then abruptly falls to below the initial constitutive level prior to the occurrence of maximal internucleosomal DNA cleavage. 5 In view of these observations, enhanced nbl expression levels could be considered as 'priming' a cell for apoptosis. Cell types which constitutively express nbl at low levels, such as thymocytes, appear to undergo an enhancement of nbl expression for 'priming', followed by abrupt suppression. However, cells such as HL-60 and Jurkat could be regarded as having already undergone the early 'priming' steps involving, at least, the enhancement of nbl expression and have maintained such enhanced levels constitutively. In such cells, apoptosis could be potentially triggered at the 'second step', ie by suppressing these elevated nbl levels, as suggested by our findings in HL-60 and Jurkat cells.
The results of this work together with previous observations suggest a possible model in which the apoptotic process involves an enhancement of nbl expression, either existing constitutively or transiently induced depending on cell type, followed by suppression. Various observations support the requirement for an enhancement of nbl expression to precede its suppression. We have previously found that the ability of Act D to block glucocorticoid-induced thymic apoptosis in vivo is highly temporal-specific, and that a marked enhancement in nbl expression specifically occurs during this narrow 'window'. 5 The subsequent abrupt fall in these transiently elevated nbl levels occurred at a stage when Act D was no longer able to block thymic apoptosis. Suppressing an already low level of nbl expression does not appear to induce apoptosis, as suggested by the failure of nbl antisense oligomers to induce apoptosis in HepG2 cells. In addition, HepG2 and other cell lines which constitutively express nbl at low levels do not demonstrate morphological or biochemical features typical of apoptosis in response to Act D. 6 The high potency of Act D treatment in inducing apoptosis in HL-60 cells, 6 compared to either of the two nbl antisense approaches, may be due at least in part to the ability of Act D to reduce nbl levels more effectively than antisense-mediated inhibition. This may be attributable to experimental conditions such as Act D being more efficiently taken up by cells than oligomers or plasmid DNA, as suggested by the heterogenous appearance of cells incubated with nbl antisense oligomers or transfected with nbl antisense sequences. However, in view that apoptosis is a multi-gene process, it is possible that the high potency of Act D is due to its suppression of not only nbl but other genes whose products could be involved in a repressor or survival factor mechanism such as bcl-2. A number of studies have demonstrated that antisensemediated inhibition of various genes, particularly several oncogenes, can result in growth-inhibition and/or apoptotic induction. [2] [3] [4] 13, 15, 18 It should also be noted that inducing apoptosis by macromolecular synthesis inhibitors is an experimental phenomenon and the physiological signals which specifically and efficiently switch off certain apoptosis-related genes require further investigation. Such mechanisms may be specific and need to be distinguished from general gene suppression due to the eventual disintegration of transcriptional and translational machinery in dying cells. Our earlier findings in mouse thymus in vivo support the notion, suggested by the present studies, that suppression of enhanced nbl levels is not merely a passive consequence of the disintegration of gene machinery. Levels of nbl in thymus, which were transiently elevated following DEX administration, were observed to abruptly fall during a period in which myc levels temporarily rose and ubiquitin expression continued at the same level. 5 Furthermore, thymic weight continued to steadily decrease for a number of hours after nbl levels had fallen.
The nbl gene is constitutively expressed at low levels in all normal tissues studied to date. 5 The high levels of nbl observed in many, though not all tumour cells 5, 6 raise the possibility that nbl could be involved in oncogenesis. One intriguing finding is that the predicted amino acid sequence of the original nbl cDNA clone appears identical, except for one residue, to that of the human fte-1 gene product. 5 fte-1 has been implicated as an effector of v-fos transformation in rodents and its expression is enhanced in v-fos-transformed fibroblasts. 20 It is possible that nbl, when expressed at low levels, is normally involved in regulating cell growth and, when expressed at high levels under certain conditions, could be potentially oncogenic. The relationship between oncogenesis and apoptosis is complex. For example, the transcription factor E2F-1 has been found to act as an oncogene, a suppressor of cell proliferation or a promoter of apoptosis, depending on its level of expression and cellular environment. 21 In some cases, apoptosis can apparently be induced by switching off an oncogene responsible for the ontogeny and progression of a specific tumour. A well-characterized example is the ability of antisense oligomers targeting bcr-abl mRNA to trigger apoptosis in chronic myelogenous leukemia cells. 3 In view that oncogenesis is a multi-step process and that high constitutive nbl expression is a common feature of a variety of tumour cells, one possibility is that the nbl gene product is involved at some common step downstream of the action of various different oncogenes.
The possibility that nbl is a multi-functional gene is additionally supported by the apparent identity in humans of the fte-1 gene product to ribosomal protein S3a. 22 There is increasing evidence that various ribosomal proteins are multifunctional. 23 Although ribosome biogenesis is a common feature of active proliferation, whether it be normal or malignant, the possible involvement of several ribosomal proteins in oncogenesis has been raised by observations of their selectively enhanced expression in various tumors and that such enhancement has no apparent association with proliferative activity. 24, 25 Specific ribosomal proteins can also potentially modulate growth by differentially regulating protein synthesis. For example, constitutively expressed ribosomal protein L7 has been suggested to induce apoptosis by specifically blocking synthesis of anti-apoptotic factors. 26 Likewise, anti-apoptotic factors could perhaps be inhibited when nbl is suppressed, given the apparent similarity of nbl to ribosomal protein S3a. It is possible that the nbl gene produce is a multifunctional ribosomal or ribosomal-like protein which could play roles in normal cell growth and oncogenesis, as well as in apoptosis depending on the level of, and changes in, its expression and cellular/physiological environment. Antisense approaches would be of benefit in future investigations of the function of nbl in these multiple roles.
A major challenge in exploiting the intrinsic apoptotic machinery to the detriment of a tumor cell, as a potential anticancer strategy, is to specifically target such machinery in tumor cells but not in normal cells. The present study provides evidence that cell death via apoptosis can be induced by inhibiting nbl expression in cells, such as HL-60 and Jurkat, which normally express this gene at high levels, but not in cells with low constitutive nbl levels. The high constitutive nbl levels observed in many leukemic cells suggest a high potential of such cells for apoptotic induction by triggering the 'second step' described earlier, in contrast to normal cells which generally express nbl at low levels and thus are not susceptible to such apoptotic induction. It is possible that a novel strategy for inducing apoptosis in many leukemic and various other cancerous cells might include targeting nbl.
